Trent JC - Search Results

1

A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis.

McAuliffe JC, Hunt KK, Lazar AJ, Choi H, Qiao W, Thall P, Pollock RE, Benjamin RS, Trent JC. McAuliffe JC, et al. Among authors: trent jc. Ann Surg Oncol. 2009 Apr;16(4):910-9. doi: 10.1245/s10434-008-0177-7. Epub 2008 Oct 25. Ann Surg Oncol. 2009. PMID: 18953611 Free PMC article. Clinical Trial.

2

Characterization of 11 human sarcoma cell strains: evaluation of cytogenetics, tumorigenicity, metastasis, and production of angiogenic factors.

Hu M, Nicolson GL, Trent JC 2nd, Yu D, Zhang L, Lang A, Killary A, Ellis LM, Bucana CD, Pollock RE. Hu M, et al. Among authors: trent jc 2nd. Cancer. 2002 Oct 1;95(7):1569-76. doi: 10.1002/cncr.10879. Cancer. 2002. PMID: 12237927 Free article.

3

Results of a 2-arm Phase II study of 9-nitrocamptothecin in patients with advanced soft-tissue sarcomas.

Patel SR, Beach J, Papadopoulos N, Burgess MA, Trent J, Jenkins J, Benjamin RS. Patel SR, et al. Cancer. 2003 Jun 1;97(11):2848-52. doi: 10.1002/cncr.11385. Cancer. 2003. PMID: 12767099 Free article. Clinical Trial.

4

A two-arm phase II study of temozolomide in patients with advanced gastrointestinal stromal tumors and other soft tissue sarcomas.

Trent JC, Beach J, Burgess MA, Papadopolous N, Chen LL, Benjamin RS, Patel SR. Trent JC, et al. Cancer. 2003 Dec 15;98(12):2693-9. doi: 10.1002/cncr.11875. Cancer. 2003. PMID: 14669291 Free article. Clinical Trial.

5

Sarcomatous change after sellar irradiation in a growth hormone-secreting pituitary adenoma.

Prabhu SS, Aldape KD, Gagel RF, Benjamin RS, Trent JC, McCutcheon IE. Prabhu SS, et al. Among authors: trent jc. Can J Neurol Sci. 2003 Nov;30(4):378-83. doi: 10.1017/s0317167100003115. Can J Neurol Sci. 2003. PMID: 14672272

6

Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?

Scaife CL, Hunt KK, Patel SR, Benjamin RS, Burgess MA, Chen LL, Trent J, Raymond AK, Cormier JN, Pisters PW, Pollock RE, Feig BW. Scaife CL, et al. Am J Surg. 2003 Dec;186(6):665-9. doi: 10.1016/j.amjsurg.2003.08.023. Am J Surg. 2003. PMID: 14672776

7

Gastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate.

Koh JS, Trent J, Chen L, El-Naggar A, Hunt K, Pollock R, Zhang W. Koh JS, et al. Histol Histopathol. 2004 Apr;19(2):565-74. doi: 10.14670/HH-19.565. Histol Histopathol. 2004. PMID: 15024716 Review.

8

A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors.

Chen LL, Trent JC, Wu EF, Fuller GN, Ramdas L, Zhang W, Raymond AK, Prieto VG, Oyedeji CO, Hunt KK, Pollock RE, Feig BW, Hayes KJ, Choi H, Macapinlac HA, Hittelman W, Velasco MA, Patel S, Burgess MA, Benjamin RS, Frazier ML. Chen LL, et al. Among authors: trent jc. Cancer Res. 2004 Sep 1;64(17):5913-9. doi: 10.1158/0008-5472.CAN-04-0085. Cancer Res. 2004. PMID: 15342366

9

Update on the biology and therapy of gastrointestinal stromal tumors.

D'Amato G, Steinert DM, McAuliffe JC, Trent JC. D'Amato G, et al. Among authors: trent jc. Cancer Control. 2005 Jan-Feb;12(1):44-56. doi: 10.1177/107327480501200106. Cancer Control. 2005. PMID: 15668652 Free article. Review.

10

Imatinib mesylate in the treatment of gastrointestinal stromal tumour.

Steinert DM, McAuliffe JC, Trent JC. Steinert DM, et al. Among authors: trent jc. Expert Opin Pharmacother. 2005 Jan;6(1):105-13. doi: 10.1517/14656566.6.1.105. Expert Opin Pharmacother. 2005. PMID: 15709888 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

215 results

Search Page